Cme (CME) Capital Expenditures (2010 - 2026)

Cme (CME) has 17 years of Capital Expenditures data on file, last reported at $21.8 million in Q1 2026.

• Quarterly Capital Expenditures rose 53.52% year-over-year to $21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.1 million (up 3.05% YoY) and the FY2025 annual result came in at $83.5 million, down 11.17% from the prior year.
• Capital Expenditures fell to $21.8 million in Q1 2026 per CME's latest filing, from $32.5 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $32.5 million in Q4 2025 and bottomed at $14.2 million in Q1 2025.
• The 5-year median for Capital Expenditures is $20.5 million (2023), against an average of $21.5 million.
• The widest annual swing landed in 2022, when Capital Expenditures slumped 54.91%; it then soared 53.52% in 2026.
• Tracing CME's Capital Expenditures over 5 years: stood at $24.4 million in 2022, then fell by 14.75% to $20.8 million in 2023, then gained by 25.96% to $26.2 million in 2024, then increased by 24.05% to $32.5 million in 2025, then sank by 32.92% to $21.8 million in 2026.
• Per Business Quant, the three latest CME Capital Expenditures figures stand at $21.8 million (Q1 2026), $32.5 million (Q4 2025), and $18.4 million (Q3 2025).

Peer Comparison